How to Measure Nasogastric Tube (NGT) Length

The most widely taught method for measuring nasogastric tube length, known as NEX (nose-earlobe-xiphoid), consistently underestimates the distance needed to reach the stomach. A narrative review in Critical Care concluded that NEX produces too short an insertion length, and that safer alternatives should replace it.¹ Getting this measurement right matters because a tube that stops short can leave its tip or drainage holes in the esophagus, while one that goes too far can kink in the stomach or pass into the small intestine. Both mistakes create serious risks, and the evidence now points to several better approaches depending on the patient’s age and size.

The Traditional NEX Method

NEX has been the bedside standard for decades. You hold the tip of the tube at the patient’s nose, extend it to the earlobe, then down to the xiphoid process at the base of the sternum. Whatever distance you measure becomes your insertion length. It is simple, requires no equipment beyond the tube itself, and can be done in seconds. These advantages explain why it became the default technique taught in nursing and medical training programs worldwide.

The problem is that NEX maps external anatomy, and external landmarks do not reliably predict internal distances. In a study that compared predicted lengths against actual anatomical measurements, the median NEX estimate came to about 51 cm, while the median distance to the gastric body flexure (a safe target zone in the stomach) was 61 cm.² That roughly 10 cm shortfall is enough to leave the tube tip sitting in the esophagus rather than the stomach. The same study found that NEX carried a potential risk of esophageal placement in over 96% of cases and a definite risk of esophageal placement in about 15%. Those numbers are striking for a method that clinicians use millions of times per year.

A separate study looking at children reached a similar verdict: NEX-predicted distances often fell shorter than the distance to the gastroesophageal junction or overshot the distal margin of the stomach body, making placement unpredictable.³ In short, the technique that most clinicians learn first is the one with the weakest evidence behind it.

Better Measurement Approaches for Adults

Recognizing NEX’s limitations, researchers have tested several modified techniques. The two with the strongest evidence in adults are NEX plus 10 cm and a regression-based formula sometimes called the Hanson equation with an added correction.

NEX plus 10 cm is exactly what it sounds like: measure NEX the usual way, then add 10 cm before marking the tube. A systematic review found that this approach produced a mean predicted length of about 60 to 61 cm and could achieve accuracy as high as roughly 97%.⁴ In the study comparing multiple methods against actual anatomy, the NEX+10 prediction (median 61 cm) matched the median gastric body flexure distance, and its definite risk of esophageal placement was 0%, compared with nearly 15% for plain NEX.²

A second formula tested in the same systematic review used a regression equation applied to the NEX distance, then added 6 cm. This method yielded slightly shorter predictions (about 56 to 57 cm on average) but achieved accuracy as high as 99% for placing the tube in the stomach.⁴ It is more cumbersome to calculate at the bedside, which has limited its adoption in fast-paced clinical settings, but it does appear to give slightly more consistent results across different body types.

There are also efforts to build prediction equations from anthropometric measurements alone. One study derived a formula using patient height and sitting height, finding that insertion length correlated most strongly with standing height.⁵ These equations show promise but need wider validation before they can replace simpler methods. For most adult patients, NEX+10 is the easiest upgrade to make today: it uses the same landmarks clinicians already know, just with an added margin that accounts for the distance NEX consistently misses.

Why NEX+10 Still Has Limits

Adding 10 cm to NEX dramatically reduces the chance of leaving the tube in the esophagus, but it does not eliminate all risk. The study that found 0% definite esophageal misplacement with NEX+10 still reported about 43% potential risk of esophageal placement, meaning the tube could theoretically end up too high in a substantial minority of body types.² The gap between “definite” and “potential” risk matters: definite risk means the predicted length places the tube tip above the gastroesophageal junction in all anatomic configurations, while potential risk means it could depending on individual variation. Still, any method that relies on a fixed correction applied to a surface measurement will struggle with extremes of body habitus, torso proportions, or anatomical anomalies like hiatal hernia.

This is the underlying tension in NGT length measurement. External landmarks are fast and cheap but imprecise. The more precise you want to be, the more you need either imaging or real-time guidance, both of which add cost and delay.

Measuring NGT Length in Children and Newborns

Pediatric patients pose an additional challenge because their internal anatomy varies enormously with age, size, and development. NEX performs even worse in this population: in one study of children aged one month to 17 years, only about 59% of NEX-guided tubes were correctly placed in the stomach, pylorus, or duodenum.⁶ Two alternative methods performed far better in that trial.

The first, called NEMU (nose-earlobe-mid-umbilicus), extends the measurement landmark from the xiphoid process down to a point halfway between the xiphoid and the navel. This added a few centimeters to the predicted length and raised correct placement to about 97%. The second, ARHB (age-related height-based), uses growth charts to derive insertion length from the child’s height. It achieved roughly 89% correct placement in the same study.⁶ The odds of misplacement using NEX rather than NEMU were over 23 times greater.

Neonates showed a similar pattern. A study of newborns found that tubes placed using NEX were correctly positioned only about 61% of the time, compared with 92% for NEMU and 100% for ARHB.⁷ The odds of misplacement were about eight times higher with NEX than with NEMU in this age group.

Weight-Based Formulas for the Smallest Infants

For newborns who are difficult to position for external measurements, weight-based formulas offer an alternative. One widely cited formula predicts nasogastric tube insertion length as 3 times the infant’s weight in kilograms plus 13 cm. The corresponding orogastric formula (for tubes inserted through the mouth) is 3 times weight plus 12 cm. This formula correctly identified all misplaced nasogastric tubes in the derivation cohort.⁸

Extremely low birth weight infants (under 1 kg) need a separate formula because their anatomy differs even from slightly larger premature babies. A study of these very small patients derived an adjusted equation: 5 times weight in kilograms plus 10 cm for infants under 1 kg, and 3 times weight plus 12.5 cm for those between 1 and 2.5 kg.⁹ The fact that separate formulas are needed for different weight ranges highlights how much anatomical proportions shift during early development.

What Happens When Measurement Goes Wrong

Mismeasured NGT length leads to two categories of problems depending on the direction of the error. A tube that is too short tends to sit in the esophagus, and a tube that is too long can coil inside the stomach or advance into the duodenum.¹

Esophageal positioning is the more immediately dangerous error. If enteral feed or medication is delivered into the esophagus rather than the stomach, the patient can aspirate liquid into the lungs. Aspiration pneumonia is a well-recognized complication of displaced feeding tubes and can be fatal in frail or critically ill patients. Beyond aspiration, a tube that wanders during insertion can enter the airway altogether. Case reports have described intrabronchial malposition leading to severe pleuropulmonary complications, and in one case, a guidewire-containing tube perforated both the esophagus and the tracheal wall.¹⁰

Tubes inserted too far can cause mechanical damage to the stomach or small bowel. Although gastric perforation from an NGT is rare, it is life-threatening when it occurs. A case report described delayed gastric perforation in an adult with end-stage heart failure, a reminder that the stomach wall in debilitated patients may be especially vulnerable to pressure from a tube tip resting against it for extended periods.¹¹ Even without perforation, a tube that kinks or curls upward after overshooting may effectively migrate back into the esophagus, creating the same aspiration risk as a tube that was too short in the first place.

Confirming Placement After Insertion

Measuring the correct length before insertion is only half the equation. Confirming that the tube tip actually ended up in the stomach is the other half, and neither step substitutes for the other.

Chest X-ray remains the gold standard for verification, but it has important limitations. An X-ray taken after placement can confirm position at that moment, yet about 1.5% of blindly placed tubes enter the lung, meaning the X-ray discovers the problem only after the damage may already be done.¹² There are also delays: waiting for radiology to process the image means feeding or medication delivery stalls, sometimes for hours. And misinterpretation is a real concern, particularly when non-radiologists are reading the films.¹³

Bedside pH testing of aspirated fluid is faster and cheaper. If you draw fluid from the tube and it has a pH of 5.5 or lower, there is a very high probability the tube is in the stomach: one study found gastric placement in nearly 99% of samples meeting that threshold. However, pH testing only works when you can actually obtain an aspirate, and sensitivity was about 78%, meaning some correctly placed tubes produce aspirates that do not clearly read as gastric. Specificity sat at roughly 86%.¹⁴

The auscultatory method, where a clinician listens with a stethoscope over the stomach while injecting air through the tube, is widely used but unreliable. The same study found it had a sensitivity of 79% but a specificity of only 61%, meaning air insufflation sounds can be heard even when the tube is in the wrong place.¹⁴ Many clinical guidelines now advise against using the “whoosh test” as the sole method of confirmation.

Electromagnetic and Magnetic Tracking Devices

The limitations of after-the-fact verification have driven interest in real-time tracking during insertion. Electromagnetic (EM) tracking systems use a small sensor in or near the tube tip that generates signals detected by an external receiver. The clinician can watch the tube’s path on a screen as it advances, ideally catching a wrong turn into the airway before any harm occurs.

One study comparing EM tracing to X-ray found 100% agreement between the two methods for confirming tube position. More importantly, the EM trace warned of lung placement during insertion in 7% of cases, giving clinicians a chance to redirect before the tube was seated in the wrong place. Neither pH testing nor post-placement X-ray can provide that kind of early warning.¹⁵ The researchers suggested EM tracing could stand alone as a confirmation method, replacing X-ray entirely.

Cost has been the main barrier to wider adoption. Existing commercial EM systems are expensive and typically limited to hospitals that can justify the investment. That has spurred work on cheaper alternatives. A low-cost magnetic tracking prototype using just two magnetic sensors demonstrated tracking accuracy within 2 to 5 mm in experimental conditions, suggesting that point-of-care tracking need not require high-end equipment.¹⁶ A separate clinical feasibility trial of a low-cost magnet-based device achieved tracking that deviated from X-ray position by an average of about 0.5 to 1.6 cm in subjects where tracking was successful, with a downward tracking range of 17 to 22 cm from the sternal angle.¹⁷ Sensor placement mattered: positioning the upper sensor pair on the sternal angle rather than the xiphoid process produced more reliable results. These devices are not yet in routine clinical use, but they represent a plausible path toward real-time verification without X-ray.

Practical Tips for Getting It Right

If you are a clinician or student learning to place NGTs, a few points are worth keeping in mind beyond which formula to use.

First, measure while the patient is in an upright or semi-upright position whenever possible. Torso length changes subtly with posture, and measuring while the patient is supine can introduce a few centimeters of error in either direction. Mark the tube clearly at the measured point before you begin insertion, and note the length on the patient’s chart so that anyone checking tube position later knows what insertion depth to expect.

Second, never rely on a single confirmation method. Even if you have measured carefully using NEX+10 or a formula-based approach, check placement with pH testing of aspirated fluid and order an X-ray when there is any doubt. The measurement gets you close; verification proves you are there.

Third, re-check periodically. Tubes migrate. Coughing, vomiting, repositioning in bed, and even routine patient care can shift a tube by several centimeters. A tube that was confirmed in the stomach at 8 a.m. may no longer be there by noon. Many institutions have protocols requiring regular checks of the external tube marking against the documented insertion length, along with repeat pH testing before each feeding.

Oral Versus Nasal Routes

Most of the measurement literature focuses on nasogastric tubes, but orogastric tubes inserted through the mouth are used regularly in certain settings, especially in intubated ICU patients and in neonates whose tiny nasal passages make nasal insertion difficult. The oral route is slightly shorter to the stomach because it skips the nasal passage and nasopharynx, which is why the neonatal weight-based formulas subtract a centimeter for orogastric compared to nasogastric placement.⁸

An ongoing large randomized trial in 16 French intensive care units is comparing nasogastric and orogastric placement head to head, primarily looking at rates of ventilator-associated pneumonia. Its protocol notes that if nasal insertion fails, the oral route is tried next and vice versa, with a change in insertion site recommended after three failed attempts or if complications arise.¹⁸ The results of that trial may eventually shift practice in ICUs, but for now the measurement principles are the same for both routes: external landmarks or formulas to predict internal distance, followed by verification.

When Standard Methods Do Not Apply

Patients with altered anatomy present unique measurement challenges. A large hiatal hernia, for instance, displaces the gastroesophageal junction upward into the chest, meaning a tube that measures correctly for a typical patient may overshoot into the herniated stomach pouch or fall short of the true gastric body. Patients with severe kyphosis (curvature of the upper spine) have shortened external torso dimensions that may not reflect their actual internal esophageal length. Obese patients often have longer intra-abdominal distances than surface measurements suggest. In all of these cases, standard NEX or even NEX+10 can be unreliable, and imaging-guided placement or real-time tracking becomes especially valuable.

Critically ill patients who are sedated and intubated present a different kind of difficulty. They cannot swallow on command to help the tube pass the cricopharyngeal sphincter, and the endotracheal tube occupies space in the airway that makes passage trickier. Failed insertion attempts are common in this population. Multiple attempts increase the risk of mucosal injury, and each retry consumes time in a setting where delays matter. Having a well-measured insertion length before the first attempt reduces the number of repositioning maneuvers needed once the tube passes the pharynx.

Bariatric surgery patients, particularly those who have undergone sleeve gastrectomy or Roux-en-Y gastric bypass, have profoundly altered gastric anatomy. In a gastric sleeve, the stomach is a narrow tube rather than a pouch, and the functional distance from the esophageal junction to the appropriate resting point for a tube tip may be very different from what any standard formula predicts. In a Roux-en-Y, the stomach pouch is tiny, and a tube inserted too far can enter a surgical anastomosis. Measurement in these patients almost always warrants imaging guidance rather than bedside estimation.

1
PubMed Central. Nasogastric tube insertion length measurement and tip verification in adults: a narrative review
2
PubMed. Methods of Estimating Nasogastric Tube Length: All, Including “NEX,” Are Unsafe
3
PubMed. Predicting internal distance to the stomach for positioning nasogastric and orogastric feeding tubes in children
4
PubMed. The accuracy of methods for determining the internal length of a nasogastric tube in adult patients: a systematic review
5
PubMed Central. Study on Influencing Factors Analysis of Gastric Tube Insertion Length and Construction of Estimation Method
6
PubMed Central. Comparing Methods of Determining Insertion Length for Placing Gastric Tubes in Children 1 Month to 17 Years of Age
7
Journal of Obstetric, Gynecologic & Neonatal Nursing. Predicting the Insertion Length for Gastric Tube Placement in Neonates
8
PubMed. A weight-based formula for the estimation of gastric tube insertion length in newborns
9
PubMed. Weight-Based Estimation of Insertion Length of the Nasogastric Tube in Extremely Low Birth-Weight Infants
10
Global Journal of Respiratory Care. Bronchopulmonary Complications of Nasogastric tube Placement
11
PubMed Central. Delayed Gastric Perforation by Nasogastric Tube: A Case Report
12
PubMed Central. X-ray checks of NG tube position: a case for guided tube placement
13
PubMed Central. Improving Outcomes Through Radiologic Verification: A Quality Improvement Approach to Nasogastric Tube Placement
14
International Journal of Nursing Studies. Reliability of pH measurement and the auscultatory method to confirm the position of a nasogastric tube
15
PubMed. Confirming nasogastric tube position with electromagnetic tracking versus pH or X-ray and tube radio-opacity
16
PubMed Central. A Low-Cost, Point-of-Care Test for Confirmation of Nasogastric Tube Placement via Magnetic Field Tracking
17
Scientific Reports. Feasibility of a low-cost magnet tracking device in confirming nasogastric tube placement at point of care, a clinical trial
18
PubMed Central. Effect of nasogastric versus orogastric tube placement on ventilator-associated pneumonia incidence in critically ill patients: a study protocol for a cluster randomised crossover trial in 16 intensive care units in France (SONG trial)